ChemPartner PharmaTech Co.,Ltd. (SHE:300149)

Market Cap	5.47B +79.6%
Revenue (ttm)	1.07B +5.7%
Net Income	-157.72M
EPS	-0.31
Shares Out	497.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,712,705
Average Volume	14,170,819
Open	11.15
Previous Close	11.10
Day's Range	10.98 - 11.19
52-Week Range	4.86 - 15.28
Beta	1.25
RSI	51.84
Earnings Date	Apr 29, 2026

About ChemPartner PharmaTech

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehensive chemical drug research and development and biological drug services for large and medium-sized pharmaceutical companies, biotechnology companies,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 1,814
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300149

Financial Performance

In 2024, ChemPartner PharmaTech's revenue was 970.20 million, a decrease of -14.77% compared to the previous year's 1.14 billion. Losses were -226.47 million, -75.30% less than in 2023.